Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.61)
# 774
Out of 5,127 analysts
86
Total ratings
40.48%
Success rate
10.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PALI Palisade Bio | Initiates: Overweight | $25 | $1.90 | +1,215.79% | 1 | Dec 29, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Overweight | $540 → $900 | $556.22 | +61.81% | 5 | Dec 19, 2025 | |
| ORKA Oruka Therapeutics | Initiates: Overweight | $75 | $26.40 | +184.09% | 1 | Dec 18, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Overweight | $140 → $72 | $6.77 | +963.52% | 2 | Nov 11, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $15 → $36 | $9.05 | +297.79% | 5 | Oct 28, 2025 | |
| LBRX LB Pharmaceuticals | Initiates: Overweight | $78 | $20.80 | +275.00% | 1 | Oct 6, 2025 | |
| TENX Tenax Therapeutics | Initiates: Overweight | $20 | $13.12 | +52.44% | 1 | Sep 8, 2025 | |
| IVA Inventiva | Initiates: Overweight | $26 | $4.92 | +428.46% | 1 | Aug 27, 2025 | |
| PLRX Pliant Therapeutics | Maintains: Overweight | $17 → $4 | $1.31 | +205.34% | 2 | Aug 8, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $78 | $4.23 | +1,743.97% | 1 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $145 | $45.50 | +218.68% | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 | $24.97 | +104.25% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $6 | $1.18 | +408.47% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $17.11 | +180.54% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $90.01 | +3.32% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $27.54 | +172.33% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $41.44 | +153.38% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $35.80 | +3.35% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $5.26 | +394.30% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.66 | +4,125.14% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $53.24 | +82.19% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $294.38 | -8.28% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $21.46 | +254.15% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $4.08 | +512.75% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $12.18 | +146.31% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $9.18 | +30.72% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $6.12 | +1,370.59% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $9.15 | +1,867.21% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $2.50 | +500.00% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $5.76 | +177.78% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $43.80 | +82.65% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $66.98 | +38.85% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $26.31 | +116.65% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $5.57 | +1,102.87% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $80.20 | -56.36% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $13.44 | +547.32% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $10.33 | +1,594.09% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $63.32 | +13.71% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $13.84 | +261.27% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.77 | +5,081.35% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.46 | +3,835.29% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $16.40 | +2,460.98% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $81.60 | -5.64% | 1 | Jul 31, 2020 |
Palisade Bio
Dec 29, 2025
Initiates: Overweight
Price Target: $25
Current: $1.90
Upside: +1,215.79%
Madrigal Pharmaceuticals
Dec 19, 2025
Maintains: Overweight
Price Target: $540 → $900
Current: $556.22
Upside: +61.81%
Oruka Therapeutics
Dec 18, 2025
Initiates: Overweight
Price Target: $75
Current: $26.40
Upside: +184.09%
Arcturus Therapeutics Holdings
Nov 11, 2025
Maintains: Overweight
Price Target: $140 → $72
Current: $6.77
Upside: +963.52%
Prothena Corporation
Oct 28, 2025
Maintains: Overweight
Price Target: $15 → $36
Current: $9.05
Upside: +297.79%
LB Pharmaceuticals
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $20.80
Upside: +275.00%
Tenax Therapeutics
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $13.12
Upside: +52.44%
Inventiva
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $4.92
Upside: +428.46%
Pliant Therapeutics
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.31
Upside: +205.34%
Tvardi Therapeutics
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $4.23
Upside: +1,743.97%
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $45.50
Upside: +218.68%
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $24.97
Upside: +104.25%
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.18
Upside: +408.47%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $17.11
Upside: +180.54%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $90.01
Upside: +3.32%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $27.54
Upside: +172.33%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $41.44
Upside: +153.38%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $35.80
Upside: +3.35%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $5.26
Upside: +394.30%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.66
Upside: +4,125.14%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $53.24
Upside: +82.19%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $294.38
Upside: -8.28%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $21.46
Upside: +254.15%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $4.08
Upside: +512.75%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $12.18
Upside: +146.31%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $9.18
Upside: +30.72%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $6.12
Upside: +1,370.59%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $9.15
Upside: +1,867.21%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $2.50
Upside: +500.00%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $5.76
Upside: +177.78%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $43.80
Upside: +82.65%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $66.98
Upside: +38.85%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $26.31
Upside: +116.65%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $5.57
Upside: +1,102.87%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $80.20
Upside: -56.36%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $13.44
Upside: +547.32%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $10.33
Upside: +1,594.09%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $63.32
Upside: +13.71%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $13.84
Upside: +261.27%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.77
Upside: +5,081.35%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.46
Upside: +3,835.29%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $16.40
Upside: +2,460.98%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $81.60
Upside: -5.64%